Clinical Trial Update: Supplementation of Lycopene in Carotid Atheroma [NA]

View source ↗

Summary

A clinical trial evaluating lycopene supplementation for carotid atherosclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis

Drugs mentioned

• Lycopene (lycopene)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Carotid Atherosclerotic Disease | NA | Status: WITHDRAWN